P53, BCL-2, and Ki-67 expression according to tumor response after concurrent chemoradiotherapy for advanced rectal cancer

Annals of Surgical Oncology

Volumn 8, Issue 5, 2001, Pages 418-424

  Kim, Nam Kyu ^a   Park, Jae Kun ^a   Lee, Kang Yong ^a   Yang, Woo Ik ^a   Yun, Seong Hyeon ^a   Sung, J ^a   Min, Jin Sik ^a  

^a Yonsei University College of Medicine   (South Korea)

Author keywords

BCL 2; Ki 67; p53; Preoperative chemoradiotherapy; Rectal cancer; Tumor response

Indexed keywords

FLUOROURACIL; FOLINIC ACID; KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ADVANCED CANCER; ARTICLE; CANCER STAGING; CELL LABELING; CELL PROLIFERATION; CLINICAL ARTICLE; GENE MUTATION; HUMAN; IMMUNOHISTOCHEMISTRY; LABELING INDEX; PREOPERATIVE CARE; PROTEIN EXPRESSION; RADIATION DOSE; RADIOSENSITIVITY; RECTUM CANCER; TUMOR VOLUME;

ADENOCARCINOMA; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; PROGNOSIS; PROTO-ONCOGENE PROTEINS C-BCL-2; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0035005156     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/aso.2001.8.5.418     Document Type: Article

References (27)

1. Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer
2. Combined modality therapy of rectal cancer: Decreased acute toxicity with the peroperative approach
3. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum
4. Changes in tumor proliferation of rectal cancer induced by preoperative 5-Fluorouracil and irradiation
5. Role of p53 and p21/WAF1 detection in patient selection for preoperative radiotherapy in rectal cancer patients
6. Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancer
7. p53 gene mutations are associated with decreased sensitivity of human lymphoma cells to DNA damaging agents
8. Radiation-induced G1 arrest is selectively mediated by the p53-WAF/CIP1 pathway in human thyroid cells
9. p53 is required for radiation induced apoptosis in mouse thymocytes
10. p53 status and the efficacy of cancer therapy 1 vivo
11. Altered p53 status correlates with differences in sensitivity to radiation induced mutation and apoptosis in two closely related human lymphoblast lines
12. p53 mutations increase resistance to ionizing radiation
13. p53 mutation does not correlate with radiosensitivity in 24 head and neck cancer cell line
14. Thymocytic apoptosis induced by p53-dependent and independent pathways
15. Loss of a p53 associated G1 checkpoint does not decrease cell survival following DNA damage
16. Immunohistochemical assessment of growth fractions in colorectal adenocarcinomas with monoclonal antibody ki-67. Relation to clinical and pathologic variables
17. Positive correlation between apoptotic and proliferative indices in gastrointestinal lymphomas of mucosa-associate lymphoid tissue (MALT)
18. Bcl-2 protects murine erythroleukemiacells from p53-dependent and independent radiation-induced cell death
19. The bcl-2 proto-oncogene and the gastrointestinal epithelial tumor and progression model
20. Bcl-2: Prevention of apoptosis as a mechanism of drug resistance
21. Immunohistochemically detectable bcl-2 expression in colorectal carcinoma: Correlation with tumor stage and patient survival
22. Bcl-2 in normal human breast and carcinoma, associated with estrogen receptor positive, epidermal growth factor receptor -negative tumor and in situ cancer
23. Bcl-2 protein in non-small cell lung carcinoma
24. Elevated expression of Bcl-x and reduced Bak in primary colorectal adenocarcinoma
25. Expression of bcl-2 protein in hyperplastic polyps, adenomas, and carcinomas of the colon
26. Bcl-2 family proteins: Strategies for overcoming chemoresistance in Cancer. Apoptosis: Pharmacological implications and therapeutic opportunities
27. Protein expression of bax, bcl-2 and p53 in patients with Non-Hodgkin's Gastric Lymphoma: Prognostic significance